The role of non‐coding RNAs, such as tsRNA‐GlyGCC, in regulating CRC progression and chemoresistance through SPIB and the JAK1/STAT6 pathway further highlights the complexity of molecular interactions in CRC disparities [20]. Here, JAK1 is linked to colorectal carcinoma.